Thermo Fisher (TMO) Advances Customer Research with New Launch
Thermo Fisher Scientific Inc. TMO recently announced the launch of the Thermo Scientific Phenom Pharos G2 Desktop Field Emission Gun – Scanning Electron Microscope (FEG-SEM). The instrument is designed to accelerate access to advanced research capabilities on nanomaterials.
The Phenom Pharos G2 advances nanomaterial research by delivering high resolutions and a wide range of acceleration voltages, all in a desktop system that can fit into a lab or office.
Recent development is likely to boost Thermo Fisher analytical instrument business.
Learn more about Phenom Pharos G2
The Phenom Pharos G2 is easy to use and highly productive, making it a versatile instrument for high volume industrial and academic laboratories. The new instrument can be installed 40% faster than the previous version, thus speeding up the time to results.
Image source: Zacks Investment Research
Users can get high resolution 2.0nm images compared to 2.5nm with the previous version. The instruments provide images in just 30 seconds for high sample throughput. It offers a simple user interface on a 24 inch widescreen display with presets to simplify use and minimize human error when organizing workflows.
Importance of the launch
The Phenom Pharos G2 is an advancement in table top microscopes that helps customers easily characterize the size, shape and chemical composition of a wide range of high resolution nanoparticles. From premium textiles and food packaging to improved solar and wind power, this easy-to-use instrument supports rapid innovation for a wide range of industries.
Materials scientists can solve the morphology of nanomaterials in materials such as metals, minerals and ceramics at a resolution of 2.0 nanometers (nm) at 20 kilovolts (kV) using the Phenom Pharos G2, facilitating thus advancements in manufacturing, electronics, clean energy and other applications.
According to a report by Grand View Research, the global nanomaterials market size was valued at $ 8.5 billion in 2019 and is expected to experience a CAGR of 13.1% by 2027.
The rapid developments in healthcare technologies, the growth of the medical diagnostics industry, the increased emphasis on research regarding nanotechnologies, and the various advantages of medical imaging applications are the factors driving the market.
In June 2021, Thermo Fisher released advanced analytical software for better data acquisition and analysis. Scientists in universities and industries, including pharmaceutical, biopharmaceutical, and food and beverage analysis, can benefit from new and improved software capabilities to improve productivity and usability. The latest software updates allow more strength and flexibility in laboratory workflows in many areas.
That same month, Thermo Fisher launched the Invitrogen Attune CytPix flow cytometer, an imaging-enhanced flow cytometer that combines acoustically focused flow cytometry technology with a high-speed camera. This modular benchtop instrument allows researchers working in QA / QC or cell therapy applications to collect additional information about their cells and sample quality without sacrificing speed when performing cytometry experiments in flow.
The company’s shares have gained 29% in one year compared to the industry’s growth of 12.6%.
Zacks rank and choice of keys
Currently the company carries a Zacks Rank # 4 (Sell).
Some better classified actions of the wider medical space are Envista Holding Company NVST, BellRing Brands, Inc. BRBR and STERIS plc STE, each wearing a Zacks Rank # 2 (Buy). You can see The full list of Zacks # 1 Rank (Strong Buy) stocks here.
Envista Holdings has an estimated long-term earnings growth rate of 26%.
BellRing Brands has an estimated long-term profit growth rate of 22%.
STERIS has a projected long-term earnings growth rate of 12%.
5 actions in the process of doubling
Each was selected by a Zacks expert as the # 1 preferred stock to earn + 100% or more in 2021. Each comes from a different industry and has unique qualities and catalysts that could fuel exceptional growth. Most of the stock in this report is flying under Wall Street’s radar, which provides a great opportunity to get into the ground floor.
Today, discover these 5 potential circuits >>
Click to get this free report
Thermo Fisher Scientific Inc. (TMO): Free Stock Analysis Report
STERIS plc (STE): Free Stock Analysis Report
Envista Holdings Corporation (NVST): free share analysis report
BellRing Brands, Inc. (BRBR): Free Stock Analysis Report
To read this article on Zacks.com, click here.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.